Actavis (ACT) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ACT Hot Sheet
Join SI Premium – FREE
Actavis (NYSE: ACT) reported Q2 EPS of $3.42, $0.06 better than the analyst estimate of $3.36. Revenue for the quarter came in at $2.67 billion versus the consensus estimate of $2.55 billion.
Actavis now sees FY2014 EPS of $13.02 - $13.32, versus the consensus of $13.73.
Actavis sees FY2015 EPS of $15.60 - $16.80, versus the consensus of $16.61.
For earnings history and earnings-related data on Actavis (ACT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- StoneX Reiterates Hold Rating on Spotify (SPOT)
- Bristol Myers Squibb MS CAR T therapy data shows patients off DMTs
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
